SCHEMBL6380971

SCHEMBL6380971

O=C1NC(=O)C(c2ccc(Oc3ccccc3)cc2)C(=O)N1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.51
MMP2 P08253 5/20 0.50
MMP9 P14780 5/20 0.50
MMP3 P08254 4/20 0.50
MMP13 P45452 3/20 0.50
MMP8 P22894 1/20 0.50
MAOA P21397 4/20 0.45
MAOB P27338 3/20 0.45
KCNH2 Q12809 1/20 0.43
SCN3A Q9NY46 1/20 0.43
GPR174 Q9BXC1 1/20 0.43
LTA4H P09960 2/20 0.43
TSHR P16473 1/20 0.43
GSTP1 P09211 1/20 0.42
SOS1 Q07889 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
PARP10 Q53GL7 1/20 0.42
PLA2G2A P14555 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5924346 0.84 MMP2 (0.38) KDM1AMMP2MMP9MMP3MMP13
SCHEMBL1639992 0.82 MAPT (0.48) KDM1AMMP2MMP9MAOAMAOB
SCHEMBL17294198 0.81 MAPT (0.46) KDM1AMMP2MMP9MAOAMAOB
SCHEMBL31579405 0.80 KDM1A (0.40) KDM1AMMP2MMP9MMP3MMP13
SCHEMBL31579542 0.79 MMP13 (0.56) MMP2MMP13MAOAMAOBKCNH2
SCHEMBL6377381 0.79 MMP2 (0.50) MMP2MMP9MMP3MMP13MMP8
SCHEMBL6385836 0.78 HPGD (0.53) KDM1AMAOAMAOBCA1CA2
SCHEMBL6794976 0.75 MAOA (0.45) MAOAMAOBCA2
SCHEMBL11585921 0.71 LTA4H (0.52) KDM1AMAOAMAOBLTA4HTSHR
SCHEMBL31579572 0.71 HAO1 (0.59) KDM1AMMP2MAOBKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025104154-A1 5-[2,7-DIAZASPIRO[3.5]NONAN-7-YL]-5-[4-PHENOXYPHENYL]HEXAHYDROPYRIMIDINE-2,4,6-TRIONE DERIVATIVES AS MMP9 INHIBITORS FOR THE TREATMENT OF DRY EYE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2025-05-22 WO disclosed
EP-0989982-B1 BARBITURIC ACID DERIVATIVES WITH ANTIMETASTATIC AND ANTITUMOR ACTIVITY ROCHE DIAGNOSTICS GMBH (DE) 2005-08-17 EP disclosed
EP-1153015-B1 PYRIMIDINE-2,4,6-TRIONES AS INHIBITORS OF MATRIX METALLOPROTEINASES HOFFMANN LA ROCHE (CH) 2004-09-29 EP disclosed
US-6716845-B2 Barbituric acid derivatives HOFFMANN-LA ROCHE INC. 2004-04-06 US disclosed
US-6472396-B1 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds ROCHE DIAGNOSTICS GMBH (DE) 2002-10-29 US disclosed
EP-0869947-B1 BARBITURIC ACID DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS ROCHE DIAGNOSTICS GMBH (DE) 2002-10-23 EP disclosed
US-6335332-B1 MATRIX METALLOPROTEASE INHIBITORS; CONTRACEPTIVES, ANTIINFLAMMATORY AGENTS ROCHE DIAGNOSTICS GMBH (DE) 2002-01-01 US disclosed
EP-1153015-A1 PYRIMIDINE-2,4,6-TRIONES AS INHIBITORS OF MATRIX METALLOPROTEINASES F. HOFFMANN-LA ROCHE AG (CH) 2001-11-14 EP disclosed
US-6265578-B1 MATRIX METALLOPROTEASE INHIBITORS HOFFMANN-LA ROCHE INC. 2001-07-24 US disclosed
US-6110924-A MATRIX METALLOPROTEASE INHIBITORS ROCHE DIAGNOSTICS GMBH (DE) 2000-08-29 US disclosed
WO-2000047565-A1 PYRIMIDINE-2,4,6-TRIONES AS INHIBITORS OF MATRIX METALLOPROTEINASES F. HOFFMANN-LA ROCHE AG (CH) 2000-08-17 WO disclosed
EP-0869947-A1 NEW BARBITURIC ACID DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS Roche Diagnostics GmbH (DE) 1998-10-14 EP disclosed
WO-1997023465-A1 NEW BARBITURIC ACID DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS BOEHRINGER MANNHEIM GMBH (DE) 1997-07-03 WO disclosed